ライフサイエンスコーパス: score of

1 line second highest FRI of 1 had a follow-up score of 0 (47% to 54%), while about a third had a follo

2 an Investigator Global Assessment response (score of 0 [clear] or 1 [almost clear] with a >=2-grade

3 plaque thickening, scaling, and erythema; a score of 0 indicates clear, 1 almost clear, and 4 severe

4 o the next until reaching a median pain-free score of 0 on POD49.

5 patients [32] vs. 7% [3]), Clinical Activity Score of 0 or 1 (59% [24] vs. 21% [9]), the mean change

6 in proptosis of >=2 mm), a Clinical Activity Score of 0 or 1 (indicating no or minimal inflammation),

7 onfidence interval [CI], 38.1 to 65.4) for a score of 0 or 1, 25.5 (95% CI, 18.3 to 32.8) for a score

8 ooperative Oncology Group performance status score of 0 or 1, and a measurable lesion as defined by R

9 ed, and if they had a WHO performance status score of 0 or 1.

10 d Rankin Scale [mRS] score; range, 0-6); mRS score of 0 to 1 (freedom from disability) or no change f

11 ) or no change from baseline at 90 days; mRS score of 0 to 2 (functional independence) or no change f

12 Compared with an unweighted allele score of 0 to 3, individuals with an allele score 7 to 1

13 The primary outcome was a score of 0 to 3, representing a favorable outcome, on th

14 ficacy end point was a modified Rankin Scale score of 0-1 at 90 days, adjusted for age and symptom se

15 y outcome was favourable functional outcome (score of 0-1 on the modified Rankin Scale [mRS]) at 90 d

16 analysis revealed 4 grades of total severity score of 0-11 (stage 0), 12-16 (stage 1), 17-22 (stage 2

17 (59.2%) of 556 with placebo achieved an mRS score of 0-2 at 90 days (adjusted risk ratio 1.04, 95% C

18 tcome was defined as a modified Rankin Scale score of 0-2 or a Glasgow Outcome Scale score of 4-5.

19 ooperative Oncology Group performance status score of 0-2.

20 on, defined as a modified Rankin Scale (mRS) score of 0-2.

21 ooperative Oncology Group performance status score of 0-2.

22 Patients with a score of 0-8 (76% of the sample) had a low (0.3%) risk o

23 respectively, as compared with those with a score of 0.

24 ty for MaSBO with an optimism-adjusted Brier score of 0.114 and area under the curve of 0.735.

25 with a median immediate improvement in BMI Z-score of 0.2 per month following the institution of gast

26 oost model has achieved a normalized utility score of 0.318 on full test data.

27 ompetition dataset, three users obtained DSB score of 0.331 +/- 0.006.

28 est individual radiologist had an average F1 score of 0.60 and an accuracy of 0.60; the model had an

29 ccuracy of 0.60; the model had an average F1 score of 0.64 and an accuracy of 0.66.

30 cy was demonstrated through a cronbach alpha score of 0.66.

31 proposed method produced the highest mean F1-score of 0.668.

32 data with missing sequences, to median Dice score of 0.67.

33 as ground truth, the model had an average F1 score of 0.70 and an accuracy of 0.71 for the full test

34 e database B the RF classifier obtained a F1 score of 0.71, and AUC of 0.75.

35 atabase A, the SVM classifier achieved an F1 score of 0.74, and AUC of 0.77.

36 lusively on BraTS data reached a median Dice score of 0.81 for segmentation on BraTS test data but on

37 mall number of trainable parameters and a F1 score of 0.82.

38 of bacterial populations with an average F1 score of 0.87, an average precision of 0.87 and an avera

39 extracted from those sets reached a test F1-score of 0.875 and test accuracy of 86.2%.

40 Our best model also achieved an average F1-score of 0.94 and 0.96 on the authentication through a c

41 nt Boosting Tree classifier achieved an F(1)-Score of 0.97 on patients with additional cardiac condit

42 t Boosting Tree classifier, achieved an F(1)-Score of 0.988 on patients without additional cardiac co

43 uracy (average 10-fold cross-validation F(1)-Score of 0.992) using an external validation data, MIT-B

44 The frequencies of risk scores of 0, 1, 2, 3, 4, and 5 or 6 were 5%, 25%, 41%, 2

45 he receiver-operating-characteristic (auROC) scores of 0.73-0.79, for different antibiotics.

46 y, for ET, TC, and WT and mean Sorensen-Dice scores of 0.80, 0.83, and 0.91, respectively, for ET, TC

47 proposed models achieved mean Sorensen-Dice scores of 0.80, 0.84, and 0.91, respectively, for ET, TC

48 Random Forests yielded Area-Under-the-Curve scores of 0.81, 0.79, 0.89 and 0.90 for echogenicity, sy

49 Interreader agreement resulted in mean kappa scores of 0.89, 0.82, and 0.93 for mean ADC, baseline tu

50 eloped and subsequently validated, with item-scoring of 0-4 points (>=2 points indicating high risk f

51 n annual decline in mean standardised domain score of -0.005 (95% CI -0.010 to 0.001) in the intensiv

52 rease in the overall socioemotional problems score of -0.13 (95% CI: -0.26, 0.01) points.

53 h an adjusted difference in mean WAZ and LAZ scores of -0.29 (95% confidence interval [CI], -.46 to -

54 d from a PSI-BLAST search achieves average F-Scores of ~0.3, a performance matching that reported by

55 to 54%), while about a third had a follow-up score of 1 (34% to 38%), and a lower percentage had an i

56 stern Cooperative Oncology Group performance score of 1 or less, and a life expectancy of 12 weeks or

57 trial Fibrillation Effect on Quality-of-Life score of 1 SD (>=18 points; 3x clinically important diff

58 Fong Clinical Risk Score of 1 to 2 at the time of diagnosis resulted in lon

59 he index admission; 60% in both groups had a score of 1 to 3 on the modified Rankin scale at admissio

60 hyperexcitable patterns, and poor outcomes (score of 1-2 on Glasgow Outcome Scale) in lobar intrapar

61 XY1 IOLs was 0.9 +/- 0.8 compared to the PCO score of 1.4 +/- 1.1 for the AcrySof SN60WF IOLs (P < .0

62 Visual scores of 1 through 3 and DeltaSUV >=66% were prospectiv

63 estyle and ideal cardiovascular health (ICH) scores of 1,216 children 9 to 13 years old was performed

64 th the American-Society-of-Anesthesiologists-scores of 1-3.

65 ly, the level of concern reached the maximum score of 10 in ICU clinicians who had provided care to c

66 e respiratory syndrome coronavirus 2 (median score of 10 on 0-10 scale).

67 Q-2 scores of 2 or greater followed by PHQ-9 scores of 10 or greater (0.82 [0.76-0.86]) was not signi

68 ) was not significantly different than PHQ-9 scores of 10 or greater alone (0.86 [0.80-0.90]); specif

69 igher specificity compared with PHQ-9 cutoff scores of 10 or greater alone.

70 -III, 12% scored below -2 s.d. (score <70; a score of 100 +/- 2 s.d. is the range) in at least one do

71 ere enrolled with a mean baseline LSAS total score of 102.6 (SD 16.84).

72 The total FAQLQ-CF score of 103 children undergoing OIT improved significan

73 Women with a 21-gene recurrence score of 11 to 25 enrolled in TAILORX were randomly assi

74 sease, baseline mean Enhanced Liver Fibrosis score of 11.4 +/- 1.2 in F4 disease and 10.3 +/- 1.0 in

75 intestinal bleeding and a Glasgow-Blatchford score of 12 or higher (scores range from 0 to 23, with h

76 ed 15 years or older with Glasgow Coma Scale score of 12 or less and systolic blood pressure of 90 mm

77 lowest tertile in the main analysis and as a score of 12 or less out of 19 in the sensitivity analysi

78 Subjects with an OSDI score of 13 or above were considered symptomatic of DED,

79 At the national level, the scores of 13 of the 17 SDGs improved over time, but the

80 in the standard GVHD prophylaxis group, with scores of 13.27 (SD 10.94) in the anti-thymocyte globuli

81 tio, 6.7; 95% CI, 5.3-8.4); and those with a score of 15-18 (2%) had a high (17.7%) risk of venous th

82 tion >50%, and a normal regional wall motion score of 16 within 24 hours of admission.

83 Using a score of 161 loci, we observed a 2.4x higher risk for in

84 ensity of 88.8 +/- 6.7% and the angiogenesis score of 19.8 +/- 3.8 obtained in the animal studies ind

85 e network was generated from the association scores of 19 gene sets from OMIM.

86 and a lower percentage had an increase to a score of 2 (9% to 15%).

87 sion, their knowledge improved from a median score of 2 (interquartile range [IQR] 1 to 3) to 5 (IQR

88 with AD, an Investigator's Global Assessment score of 2 or 3 (mild or moderate), and 3% to 20% affect

89 of 0 or 1, 25.5 (95% CI, 18.3 to 32.8) for a score of 2 or 3, 7.1 (95% CI, 5.1 to 9.1) for a score of

90 with a consensus neuroradiologist confidence score of 2 or greater.

91 ooperative Oncology Group performance status score of 2 or less and adequate haematologic, hepatic, a

92 ars or older with an ECOG performance status score of 2 or lower, and were relapsed or refractory to,

93 us and American Society of Anesthesiologists score of 2 or lower, were centrally randomly assigned (1

94 ooperative Oncology Group performance status score of 2 or lower.

95 n = 145, 43%) were chest radiograph severity score of 2 or more (odds ratio, 6.2; 95% confidence inte

96 articipants with baseline second highest FRI score of 2, between 25% and 44% of participants had foll

97 ith atrial fibrillation and CHA(2)DS(2)-VASc score of 2, high genetic risk conferred a 4-fold higher

98 .2 (0.97) and the medium-volume group gave a score of 2.1 (1.36), P < 0.01.

99 he high-volume group gave unpleasant taste a score of 2.2 (0.97) and the medium-volume group gave a s

100 p instillation self-efficacy from an average score of 2.6 (standard deviation [SD], 0.3) to 2.8 (SD,

101 as a Belin/Ambrosio enhanced ectasia display score of 2.6 or more in either eye based on Pentacam ima

102 When considering scores of 2 only, (11)C-choline PET/CT positivity was 54

103 When considering scores of 2 only, (11)C-choline PET/CT positivity was 54

104 (0.88-0.94) and 0.67 (0.64-0.71) for cutoff scores of 2 or greater and 0.72 (0.67-0.77) and 0.85 (0.

105 structured interviews, sensitivity for PHQ-2 scores of 2 or greater followed by PHQ-9 scores of 10 or

106 fected than upper extremities (average fat z scores of 2.1 and 0.6, respectively).

107 hich the patient was arousable, defined as a score of -2 to -3 on the Richmond Agitation and Sedation

108 ty types, yielding an average increase in F1-score of ~2 pp compared to learning without pretraining.

109 acuity through their final visits (appETDRS score of 26 [20-35] to 35 [26-35]; Snellen, 20/300 to 20

110 mm(2); and 84% and 74%, respectively, when a score of 3 for beta = 1000 s/mm(2).

111 icity were 95% and 64%, respectively, when a score of 3 for beta = 300 s/mm(2); 90% and 69%, respecti

112 0 s/mm(2); 90% and 69%, respectively, when a score of 3 for beta = 500 s/mm(2); and 84% and 74%, resp

113 tic individuals (5% PCR positive), a CO-RADS score of 3 or greater detected SARS-CoV-2 infection with

114 protein (WASP) expression or a Zhu clinical score of 3 or higher.

115 ry outcome was a modified Rankin scale (mRS) score of 3 or lower (indicating ability to walk unassist

116 tients who were admitted, a chest radiograph score of 3 or more was an independent predictor of intub

117 All of 30 mismatched patients with a TLICS score of 3 points or less (15.8%) had stable burst fract

118 atients with a head Abbreviated Injury Scale score of 3+ and excluded those with another regional Abb

119 al outcome (defined as modified Rankin Scale score of 3-6) was reported in 29 of 113 participants (25

120 sk equivalent to those with CHA(2)DS(2)-VASc score of 3.

121 d an Expanded Disability Status Scale (EDSS) score of 3.0-6.5 were eligible for enrolment.

122 , an expanded disability status scale (EDSS) score of 3.5-6.5, a timed 25-foot walk (TW25) of less th

123 74.7 years and Society of Thoracic Surgeons score of 3.7% underwent TAVR with contemporary devices (

124 me Surveillance in Australia and New Zealand score of 3.8 (interquartile range 3.7-4.6) received flui

125 uld have a posttest probability of 4% with a score of 3/10 versus 43% with a score of 7/10.

126 clinical validity with predefined competent scores of 3 and 5 respectively.

127 (DCA/CA) ratio, along with the dysregulation scores of 3 metabolic pathways, primary bile acid biosyn

128 (0.67-0.77) and 0.85 (0.83-0.87) for cutoff scores of 3 or greater.

129 The mean CISS score of 31.6 +/- 9.0 for non-amblyopic/strabismic stude

130 For women, a score of 32 or higher (observed mortality 0.67), the pre

131 For a score of 32 or higher (observed mortality 0.68), predict

132 ogic model of end-stage liver disease (MELD) score of, 35 for dCLKT and 34 for eCLKT (P = ns).

133 A score of 4 and above on Carlsson- Dent questionnaire was

134 A CO-RADS score of 4 or greater yielded an odds ratio of 25.9 (95%

135 036) and a reduced risk of an NAFLD activity score of 4 or higher (ADH1B*2: OR, 0.83; P = .012 vs ADH

136 (modified global histologic disease activity score of 4 or less).

137 at week 26 was endoscopic remission (SES-CD score of 4 or less); other endpoints included endoscopic

138 treatment, 131 patients (94.9%) had a TLICS score of 4 points or less, and matched with the recommen

139 treatment, 160 patients (84.2%) had a TLICS score of 4 points or more (match rate 84.2%, 160/190).

140 re of 2 or 3, 7.1 (95% CI, 5.1 to 9.1) for a score of 4 to 6, and 1.2 (95% CI, 0.5 to 1.9) for a scor

141 cale score of 0-2 or a Glasgow Outcome Scale score of 4-5.

142 d an Expanded Disability Status Scale (EDSS) score of 4.0-6.5.

143 quality declined with decreasing dose (mean score of 4.1 +/- 0.4 for the standard dose, 3.4 +/- 0.7

144 rs of follow-up among individuals with PHQ-2 scores of 4 or higher vs 0 were 20.9 vs 14.2 for CHD eve

145 d best-corrected visual acuity (BCVA) letter score of 49 letters or more (>=1 GA lesion within 250 mu

146 iatric Respiratory Assessment Measure (PRAM) score of 5 or greater (on a 12-point scale) after a 1-ho

147 al Institutes of Health Stroke Scale (NIHSS) score of 5 or less (range, 0 to 42, with higher scores i

148 rave outcomes (3-month modified Rankin Scale score of 5-6).

149 d a Lansky Play/Karnofsky Performance status score of 50 or higher, received intravenous pembrolizuma

150 chemical disease relation corpus, and an F1-score of 54.4% on inter-sentential relations, which was

151 s in the dexamethasone group had a mean SOFA score of 6.1 (95% CI, 5.5-6.7) vs 7.5 (95% CI, 6.9-8.1)

152 k or relapse in the past 12 months and had a score of 6.5 or less on the Expanded Disability Status S

153 ian Quality of Life after Brain Injury total scores of 62 (no decompressive craniectomy) versus 79 (d

154 n best-corrected visual acuity from a letter score of 63.38 (+/-7.92) at baseline to 76.38 (+/-8.93)

155 Our proposed method obtained an F1-score of 63.5% on BioCreative V chemical disease relatio

156 f 4 to 6, and 1.2 (95% CI, 0.5 to 1.9) for a score of 7 or 8.

157 factor (pathological T-stage 3 or 4, Gleason score of 7-10, positive margins, or preoperative PSA >=1

158 factors to 81.9% in those with a total risk score of 7-8 (p < 0.0005 for linear trend) and in women

159 d most patients (1671 [77.6%]) had a Gleason score of 7.

160 d an Expanded Disability Status Scale (EDSS) score of 7.5 or lower, and had a history of at least two

161 of 4% with a score of 3/10 versus 43% with a score of 7/10.

162 lation sites, our method achieved efficiency scores of 79%, 68.7% and 0.48 for sensitivity, specifici

163 fied Japanese Orthopaedic Association (mJOA) score of 8-14, were eligible.

164 All nine livebirths had a 1-min Apgar score of 8-9 and a 5-min Apgar score of 9-10.

165 ian Quality of Life after Brain Injury total score of 83 (decompressive craniectomy) versus 62 (no de

166 Also, our method achieved an F1-score of 85.1% on n2c2-ADE sub-dataset.

167 e 5-minute Apgar score, with those who had a score of 9 or 10 serving as the reference group, were 51

168 a 1-min Apgar score of 8-9 and a 5-min Apgar score of 9-10.

169 risk of venous thromboembolism; those with a score of 9-14 (22%) had an intermediate (3.6%) risk of v

170 atory tract infection with a pneumonia index score of 90-130 and who were expected to be treated with

171 analysis); (18)F-FDG PET (pattern expression score of a previously defined (18)F-FDG-based AD convers

172 e of Cohen's PSS questionnaire and NEI-VFQ25 scores of acute and chronic CSC.

173 on Score (GDS) was calculated as the average score of all the pixels of the images.

174 At day 14 and day 42 test group scores of all assessed parameters were significantly imp

175 using (18)F-florbetapir (pattern expression score of an amyloid-beta AD conversion-related pattern,

176 atode Caenorhabditis elegans that allows the scoring of animal survival and health measures.

177 nced by a mean NPS higher than 6 and SNOT-22 score of approximately 60.

178 ts severity and comparing the mean or median scores of arms.

179 Polygenic scores of ASD (ASD-PGSs) were generated across the sampl

180 2 diabetes; a Patient Health Questionnaire-9 score of at least 10 (range, 0-27); and hemoglobin A1c (

181 In patients with a Krenning score of at least 3 on SSTR PET, the detection rate of p

182 Approximately 30% of eyes with a DRSS score of at least 47 receiving ranibizumab 0.5 mg per st

183 fsky (patients >16 years) performance status score of at least 50, and a new diagnosis of a WHO (2002

184 ligible for transplantation with a Karnofsky score of at least 60, and received an unrelated donor (f

185 s, and severe pruritus was defined as a mean score of at least 7 for the worst daily intensity of pru

186 ofsky (if aged >16 years) performance status score of at least 70.

187 late metabolites were associated with higher scores of autistic traits as measured by the SRS-2 in bo

188 two groups, and we estimated the propensity score of being a beneficiary of the BFP using a logit mo

189 e parameters of these distributions from the scores of best and second-best PSMs associated with each

190 g18181703 (SOCS3) was associated with higher scores of both Mediterranean-style diet score and Altern

191 ectrical model was proposed for pathological scores of breast lesions based on the theory of electric

192 ogression was compared with traditional risk scores of cardiovascular disease (CVD).

193 In contrast, FAQLQ-CF scores of control patients improved mildly and nonsignif

194 d as an adult height <= 2 standard deviation scores of control values obtained from a French populati

195 facilitate their analysis, we developed two scores of correlation between sidechain dihedral angles.

196 Second, we created polygenic risk scores of DBP and systolic blood pressure and generated

197 At 28 days, the median composite score of death and number of ventilator-free days at day

198 oordinates of 24-hour movement pattern and z scores of diet quality were used as input into a model-b

199 stantia nigra and their relation to clinical scores of disease severity in patients with early or pro

200 antioxidant capacities and overall likeness score of DP or DJ infusion were comparable with the comm

201 The TLICS score of each group was analyzed and the degree of consi

202 tion and accuracy of classifications with F1 Score of each land cover classification ranging from 64.

203 tween-visit communication, and the composite score of experience were each associated with 4% decreas

204 were assessed: a weight-length relationship, scoring of external physical damage, and after dissectio

205 he model is able to faithfully predict human scoring of facial normality.

206 3 of the 17 SDGs improved over time, but the scores of four SDGs declined.

207 detection and normalized domain overlapping scores of FUpred were 0.788 and 0.521, respectively, whi

208 ample brewed from the MRC beans had a higher score of general impression and pleasant coffee sensory

209 ly associated with risk of diabetes, whereas scores of glycosylceramides, lactosylceramides, or other

210 CI, 0.67-1.00) for discriminating a Gleason score of greater than or equal to 3 + 4 from a Gleason s

211 on of primary prostate cancer with a Gleason score of greater than or equal to 3 + 4 in men with elev

212 ity of 75% (30%-95%) for detecting a Gleason score of greater than or equal to 3 + 4.

213 For discriminating a Gleason score of greater than or equal to 4 + 3 from a Gleason s

214 could be established for detecting a Gleason score of greater than or equal to 4 + 3 with a sensitivi

215 e left ventricular end-diastolic dimension Z score of >2 exhibited a significantly greater improvemen

216 e decline defined as a composite cognitive z score of >=1.0 compared to patients without long-term co

217 mperature >100.4 degrees C (1 point), with a score of >=3 indicating influenza testing was warranted.

218 All subjects reported a satisfaction score of >=3.5 of 5 and required no spectacles postopera

219 rade and lower-grade primary tumors (Gleason score of >=4 + 3 vs. <3 + 4).

220 previously derived PREDICT model, the day 1 score of >=4 had a sensitivity of 30.4% and a specificit

221 otor disease and disturbing NMS defined by a score of >=4 points on the Movement Disorder Society - U

222 001) and have a Society of Thoracic Surgeons score of >=8 (p < 0.0001), anemia (p = 0.02), chronic ki

223 All subjects had a composite score of >=90 for vision-targeted items in the National

224 with an increase in the average mathematics scores of high-school boys relative to girls.

225 Coupled with histopathology findings, scoring of images that contained early-stage neoplasia i

226 A composite score of individual psychosocial resilience was created

227 Fleiss kappa value was calculated, and scores of individual observers were compared with the me

228 The primary scores of interest were the Total Symptom Score, Physica

229 algorithms and compared with rank normalized scores of internal five-fold cross-validation statistics

230 The average scores of K-MMSE in patients with MCI improved by 8% aft

231 Poor cognitive function was defined as a score of less than 18 on the Chinese version of the Mini

232 ooperative Oncology Group performance status score of less than 3 (Karnofsky Performance Status score

233 Poor quality studies were those, which had a score of less than 33% on the QATSO tool.

234 or a composite motor or composite cognitive score of less than 70 (which corresponds to 2 SD below t

235 reater than or equal to 3 + 4 from a Gleason score of less than or equal to 3 + 3.

236 reater than or equal to 4 + 3 from a Gleason score of less than or equal to 3 + 4, a cutoff could be

237 in 68 cortical areas were identified using Z-scores of LGI (hyper: Z >= 2.58, hypo: Z <= - 2.58).

238 SPPB impairment was defined as a score of <=10.

239 4% and a specificity of 93.8%, whereas day 5 score of <=2 had a sensitivity and negative predictive v

240 r severe cognitive impairment (AUC, 0.81); a score of <=21 had a sensitivity of 86% and specificity o

241 DNAm-based risk scores of MDD significantly discriminated MDD cases from

242 with a graphical interface that allows both scoring of miRNA reliability and browsing of supporting

243 d had a Modified Fatigue Impact Scale (MFIS) score of more than 33 were recruited at two academic mul

244 th iRBD and Parkinson's disease and clinical scores of motor disability, cognition and mood/behaviour

245 A polygenic score of MRI-derived left ventricular end systolic volum

246 The percentage of subjects with a CGI-I score of much or very much improved was also significant

247 ery disease (CAD) can be evaluated as a risk score of multiple variants.

248 Further, a combinatorial score of NEK10 and TP53-target gene expression is an ind

249 to score proteins to generate a druggability score of novel targets.

250 g loss-of-function mutation intolerant and Z-scores of observed/expected synonymous and non-synonymou

251 Specifically, the F1 scores of our best performing model are 85.29% on BC2GM,

252 n the basis of Health Utilities Index Mark 3 scores of patients with CP versus controls.

253 o noticeable trend with dose level; however, scores of PET-only images were lower for low-dose scans,

254 Likert scoring of PET/MR images showed no noticeable trend with

255 , there was no significant difference in the scores of PI, BOP, PD, clinical AL and MBL when SRP was

256 BionoiNet also computes significance scores of pocket atoms, called BionoiScores, to provide

257 ciations between 7 subscales and 1 composite score of PREs and 30-day morbidity, unplanned readmissio

258 trate that SeedGerm could match specialists' scoring of radicle emergence.

259 We transformed DeepSAV scores of rare SAVs in the human population into a quant

260 From the DGIE scores of relevant subnetworks, we infer that the functi

261 The mean score of reported generic health status assessed by the

262 The score of rhinitis severity (range, 0-12), based on inten

263 The median (1st quartile-3rd quartile) score of rhinitis severity was 4 (2-6).

264 ical activity were used to establish a total score of risk factors, with higher scores indicating an

265 The average scores of safety emphasis, face-saving, power distance,

266 Our analysis unveiled scores of signaling pathways linked to native islet beta

267 sectioning, confocal microscopy, and manual scoring of specific regions of interest have been used t

268 ; 95% CI: 1.24, 4.65; P-trend = 0.003) and a score of sphingomyelins with fully saturated sphingoid-f

269 egression analysis to determine a predictive score of surgically confirmed IH in the Geneva training

270 A diary score of symptoms was collected from allergic patients.

271 utopsy reports were used to develop a global score of systemic vascular disease that included aorta a

272 ncology clinical trial drugs compared to the scores of targets of trial drugs for other indications.

273 MP-PCA denoising led to a higher median z score of task-based functional MRI voxel activation in l

274 Pin-prick score of the 25 patients with neuropathic pain increased

275 erall knowledge, attitudes, and habits (KAH) score of the children at 5 months.

276 cebo did not improve the physical limitation score of the KCCQ.

277 nimisation variables, baseline cluster-level score of the outcome, and sociodemographic characteristi

278 ty index, content validity ratio, and impact score of the Persian version of CDAT (Pv-CDAT) were 0.97

279 ructure identification, where the average TM-score of the template alignments has over 7.5% increases

280 The mean objective PCO score of the Vivinex XY1 IOLs was 0.9 +/- 0.8 compared t

281 After one day of treatment, the total RBANS scores of the 20 mg and 5 mg tropisetron groups, and the

282 The MDD patients had lower scores of the CSIT and SROS and longer DeltaMRT at basel

283 tic accuracy was determined by comparing the scores of the DWI data set to those of the clinical refe

284 PD was assessed using sum scores of the Everyday Discrimination Scale (EDS).

285 ositively associated with consistently lower scores of the healthy dietary pattern.

286 diagnoses, can be accurately predicted from scores of the Mini-Mental Status Exam, protein levels in

287 ession, we predicted physical health summary scores of the participants at age 50 years from the 12-i

288 square meter) and positively correlated with scores of the personality trait constraint independent o

289 ent family were positively related to higher scores of the Western dietary pattern.

290 The deformation score of this signature predicted conversion to a synucl

291 s no difference in the primary outcome (rank score of time to death, time to rehospitalization for he

292 fication accuracy, precision, recall, and F1 score of TMS in differentiating each neurodegenerative d

293 Qualitative visual scoring of tumor conspicuity also showed shorter overall

294 Hospital-level, risk-standardized measure scores of unplanned hospital visits (emergency departmen

295 e number of patients at day 90 with an NIHSS score of up to 5 (95 [61%] of 156 in 150 mg S44819 group

296 cted distance visual acuity (CDVA), severity scores of various ocular surface parameters, and the occ

297 these 314 patients, 404 thyroid nodules were scored, of which 19.1% (77 of 404) were malignant.

298 eline and one or more follow-up MoCA or DSST scores, of whom 4456 were assigned dulaglutide and 4372

299 ilar, low risk for ASCVD as those with a CAC score of zero.

300 n (hs-cTn) and coronary artery calcium (CAC) scores of zero are associated with a low risk for athero